Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Durogesic 100µg/h
Active Ingredient: Fentanyl 16.8mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium
Product: Durogesic 12µg/h
Active Ingredient: Fentanyl 2.1mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium
Product: Durogesic 25µg/h
Active Ingredient: Fentanyl 4.2mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium
Product: Durogesic 50µg/h
Active Ingredient Fentanyl 8.4mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium
Product: Durogesic 75µg/h
Active Ingredient: Fentanyl 12.6mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium
Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: DSM Pharmaceuticals Inc, North Carolina, United States of America
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: DSM Pharmaceuticals Inc, North Carolina, United States of America
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Wyeth Medica Ireland, Dublin, Ireland
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Wyeth Medica Ireland, Dublin, Ireland
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Dated this 20th day of August 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).